- Report
- March 2023
- 64 Pages
Europe
From €1438EUR$1,500USD£1,202GBP
- Report
- October 2024
- 83 Pages
Global
From €3500EUR$3,911USD£3,027GBP
- Report
- October 2024
- 100 Pages
Global
From €3500EUR$3,911USD£3,027GBP
- Report
- February 2024
- 101 Pages
Global
From €3500EUR$3,911USD£3,027GBP
- Report
- June 2022
- 53 Pages
Global
From €1917EUR$2,000USD£1,602GBP
Omeprazole is a proton pump inhibitor used to treat gastrointestinal disorders such as gastroesophageal reflux disease (GERD), peptic ulcer disease, and erosive esophagitis. It is also used to reduce the risk of gastric ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs). Omeprazole works by blocking the enzyme in the stomach that produces acid, thus reducing the amount of acid in the stomach.
Omeprazole is available in both prescription and over-the-counter (OTC) forms. Prescription forms are typically used to treat more severe cases of GERD and other gastrointestinal disorders, while OTC forms are used to treat milder cases. Omeprazole is also available in combination with other medications, such as antibiotics, to treat more severe cases of GERD and other gastrointestinal disorders.
The market for Omeprazole is highly competitive, with many pharmaceutical companies offering their own versions of the drug. Some of the major players in the market include Pfizer, AstraZeneca, GlaxoSmithKline, Merck, and Novartis. Show Less Read more
